Published in J Biol Chem on November 10, 2010
Chlamydial Plasmid-Encoded Virulence Factor Pgp3 Neutralizes the Antichlamydial Activity of Human Cathelicidin LL-37. Infect Immun (2015) 0.80
Streptococcus pyogenes triggers activation of the human contact system by streptokinase. Infect Immun (2015) 0.79
Chlamydial Plasmid-Dependent Pathogenicity. Trends Microbiol (2016) 0.77
Streptococcal surface proteins activate the contact system and control its antibacterial activity. J Biol Chem (2012) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
Neutrophil extracellular traps kill bacteria. Science (2004) 23.64
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
Ultrastructural localization of intracellular antigens by the use of protein A-gold complex. J Histochem Cytochem (1978) 7.15
Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev (1992) 4.56
Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol (1984) 3.56
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis (2009) 3.51
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol (2006) 3.03
Molecular basis of group A streptococcal virulence. Lancet Infect Dis (2003) 2.86
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2009) 2.80
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem (1996) 2.62
Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood (1997) 2.26
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun (2000) 2.19
Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis (2008) 2.14
Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05
Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis (2001) 2.00
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci U S A (1998) 1.85
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1.80
Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol (2008) 1.62
SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem (2003) 1.60
M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J (1994) 1.55
Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 1.51
Activation of the human contact system on neutrophil extracellular traps. J Innate Immun (2009) 1.41
Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res (2007) 1.38
Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun (2005) 1.37
Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett (2004) 1.36
The contact system--a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 1.36
Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology (2001) 1.31
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun (2002) 1.30
Protein H--a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin. Mol Microbiol (1994) 1.23
Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. Microb Pathog (1999) 1.19
The role of the complement system in innate immunity. Immunol Res (2005) 1.19
Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol (2010) 1.14
Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol (2005) 1.13
Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem (2005) 1.11
Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem (1995) 1.09
The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis (2007) 1.08
Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem J (1995) 1.08
The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology (2004) 1.01
Structural basis of reduction-dependent activation of human cystatin F. J Biol Chem (2006) 0.97
Regulation of complement functional efficiency by histidine-rich glycoprotein. Blood (1992) 0.95
Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem (2006) 0.94
Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J Innate Immun (2010) 0.94
Histidine-rich glycoprotein exerts antibacterial activity. FEBS J (2007) 0.94
Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood (2010) 0.93
Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood (2009) 0.93
Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006 to 2007. Scand J Infect Dis (2009) 0.86
Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities. Microbes Infect (2007) 0.86
Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta (2006) 0.84
Streptococcal inhibitor of complement-mediated lysis (SIC): an anti-inflammatory virulence determinant. Microbiology (2010) 0.79
The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius. FEMS Microbiol Lett (2009) 0.76
Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics (2008) 3.29
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell (2004) 2.46
The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem (2002) 2.44
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A (2013) 2.32
Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med (2012) 2.30
Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med (2011) 2.29
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol (2002) 2.21
Pathogenic mechanisms in lupus nephritis: Nucleosomes bind aberrant laminin β1 with high affinity and colocalize in the electron-dense deposits. Arthritis Rheumatol (2014) 2.13
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood (2010) 2.04
Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis (2009) 1.94
Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol (2009) 1.87
Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol (2002) 1.87
Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood (2011) 1.87
Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem (2013) 1.84
MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun (2003) 1.82
β₂-glycoprotein I: a novel component of innate immunity. Blood (2011) 1.75
COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem (2007) 1.74
Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem (2003) 1.72
The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem J (2003) 1.67
Genome-based identification and analysis of collagen-related structural motifs in bacterial and viral proteins. J Biol Chem (2003) 1.65
The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem (2005) 1.61
SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem (2003) 1.60
The protein expression of Streptococcus pyogenes is significantly influenced by human plasma. J Proteome Res (2005) 1.55
Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A (2011) 1.52
Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 1.51
Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet (2004) 1.51
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.48
Antimicrobial activities of heparin-binding peptides. Eur J Biochem (2004) 1.46
Anesthesia aggravates lung damage and precipitates hypotension in endotoxemic sheep. Shock (2010) 1.44
Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol (2011) 1.44
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci U S A (2008) 1.44
Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry (2004) 1.43
Activation of the human contact system on neutrophil extracellular traps. J Innate Immun (2009) 1.41
Pathogen entrapment by transglutaminase--a conserved early innate immune mechanism. PLoS Pathog (2010) 1.39
Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One (2008) 1.37
The contact system--a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 1.36
Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol (2006) 1.36
Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem (2002) 1.35
The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect Immun (2002) 1.33
Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A (2004) 1.32
Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol (2007) 1.32
Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest (2006) 1.30
Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol (2003) 1.29
Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother (2005) 1.28
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A (2008) 1.27
Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock (2008) 1.25
Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol (2002) 1.25
IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol (2010) 1.24
Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care (2012) 1.23
Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum (2010) 1.23
alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem (2004) 1.23
Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3. Cell Metab (2009) 1.22
Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem (2002) 1.22
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol (2008) 1.21
Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci U S A (2007) 1.20
Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med (2012) 1.18
Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood (2002) 1.18
Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol Chem (2011) 1.17
Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum (2007) 1.17
Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Ann Neurol (2007) 1.15
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol (2008) 1.14
Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem (2004) 1.14
Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis (2004) 1.14
Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure (2004) 1.14
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res (2005) 1.13
Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog (2010) 1.12
Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta (2007) 1.12
Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J (2004) 1.12
Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem (2005) 1.11
Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother (2008) 1.11
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol (2007) 1.11
IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One (2008) 1.10
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care (2012) 1.10
B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09
IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol (2003) 1.09
Identification of two protein-binding and functional regions of curli, a surface organelle and virulence determinant of Escherichia coli. J Biol Chem (2002) 1.09
Antimicrobial peptides derived from growth factors. Growth Factors (2007) 1.09
Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One (2012) 1.08
The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem (2002) 1.08
Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol (2012) 1.06
Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol (2006) 1.06
Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem (2006) 1.06